The National Committee for the Control of Viral Hepatitis will approve using Sovaldi and Harvoni to cure children with Hepatitis C within two weeks, Chairman Wahid Doss tells Al Mal. This follows the US FDA’s recent approval to use the medications to treat children. Doss expects the medication will be used starting from June.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…